Benitec Biopharma Inc. (BNTC)
Nasdaq: BNTC · Pharmaceutical Preparations · Hayward, CA · filing with the SEC since 2020
Filings
272 filings since 2017 beside 62 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Jun 30, 2027Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Sep 28, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 76 days after the quarter ended. The proxy statement was last filed Oct 20, 2026.
Filings a yearinsider forms included
33384549766429
2026 counts to Nov 13, 2026.
Auditor change (8-K item 4.01): 2 times in the last 36 months, the newest Sep 30, 2026.Officer or director change (8-K item 5.02): 9 times in the last 36 months, the newest May 29, 2026.Warning not to rely on past financial statements (8-K item 4.02): 1 time in the last 36 months, the newest Sep 12, 2025.SEC letters: 15 in the last 36 months, the newest Apr 3, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 7, 2025
8-K items 1.01, 8.01, 9.01
Major agreement signed; Other event · Current report
Nov 5, 2025
Nov 3, 2025
8-K items 5.02, 7.01, 8.01, 9.01
Officer or director change; Investor disclosure (Regulation FD); Other event · Current report
Nov 2, 2025
40 of 272 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.